Policy Comment Letters
As part of its advocacy mission, the Society for Women's Health Research monitors the activities of the executive branch in the areas of women's health and research. At the request of various federal agencies, SWHR periodically submits public comment letters detailing its positions on issues pertaining to SWHR's public policy priorities.
- SWHR signed on to a comment letter to the FDA regarding public availability of data about how new drugs and devices work in women, minorities, and older Americans. (November 20, 2013)
- SWHR gave oral comments
and submitted written comments to the docket at FDA REMS
Standardization and Evaluation Public Meeting at the White Oak campus. (July
- SWHR submitted comments
and Track and Trace legislation to both House and Senate leadership,
the Senate HELP committee and to the House Energy and Commerce committee,
among others. (July 23, 2013).